Sofinnova Partners ("Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment of Manohar (Mano) Iyer, a serial entrepreneur with
The nomination bolsters the firm's management and corporate functions as it continues its expansion across the entire value chain of life sciences investments Sofinnova Partners ("Sofinnova"), a
The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door
MILAN, ITALY / ACCESSWIRE / September 8, 2022 / AAVantgarde Bio, a clinical stage Milan-based international biotechnology start-up that has developed proprietary Adeno-Associated Viral (AAV) vector platforms
MILAN, ITALY / ACCESSWIRE / August 10, 2022 / Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and